2 Clarke Drive
Suite 100
Cranbury, NJ 08512
© 2024 MJH Life Sciences™ and OncLive - Clinical Oncology News, Cancer Expert Insights. All rights reserved.
Stephanie L. Graff, MD, shared the importance of personalizing care for her patients with breast cancer, how she balances her professional and personal life, using the optimal voice on social media, and her vision for the future of breast cancer treatment.
Welcome to a very special edition of OncLive On Air! I’m your host today, Gina Columbus.
OncLive On Air is a podcast from OncLive, which provides oncology professionals with the resources and information they need to provide the best patient care. In both digital and print formats, OncLive covers every angle of oncology practice, from new technology to treatment advances to important regulatory decisions.
But today, we had the pleasure of sitting down with Dr Stephanie L. Graff, MD, who is director of the Breast Program at the Sarah Cannon Cancer Institute of HCA Midwest Health and associate director of the Breast Cancer Research Program at Sarah Cannon Research Institute.
Dr Graff has had an impressive career thus far in the breast cancer field, and is known to be passionate about connecting with her patients for personalized care, and is also dedicated to advancing breast cancer research and has been a principal investigator on several clinical trials in the breast cancer field. She is also focused on breast cancer prevention, and leads the BE AWARE & Breast Cancer Prevention clinics for Sarah Cannon HCA Midwest Health.
In our exclusive interview, Dr. Graff shared with us the importance of personalizing care for her patients with breast cancer, how she balances her professional and personal life, using the optimal voice on social media, and her vision for the future of breast cancer treatment.